- Home
- ARQT vs WNC Comparison
ARQT vs WNC Comparison
Compare ARQT & WNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARQT
- WNC
- Stock Information
- Founded
- ARQT 2016
- WNC 1985
- Country
- ARQT United States
- WNC United States
- Employees
- ARQT N/A
- WNC N/A
- Industry
- ARQT Biotechnology: Pharmaceutical Preparations
- WNC Construction/Ag Equipment/Trucks
- Sector
- ARQT Health Care
- WNC Industrials
- Exchange
- ARQT Nasdaq
- WNC Nasdaq
- Market Cap
- ARQT 2.1B
- WNC 457.3M
- IPO Year
- ARQT 2020
- WNC 1991
- Fundamental
- Price
- ARQT $17.14
- WNC $10.99
- Analyst Decision
- ARQT Strong Buy
- WNC Hold
- Analyst Count
- ARQT 7
- WNC 1
- Target Price
- ARQT $19.00
- WNC $9.50
- AVG Volume (30 Days)
- ARQT 1.5M
- WNC 442.6K
- Earning Date
- ARQT 11-05-2025
- WNC 10-23-2025
- Dividend Yield
- ARQT N/A
- WNC 2.81%
- EPS Growth
- ARQT N/A
- WNC N/A
- EPS
- ARQT N/A
- WNC N/A
- Revenue
- ARQT $263,464,999.00
- WNC $1,720,560,000.00
- Revenue This Year
- ARQT $72.46
- WNC N/A
- Revenue Next Year
- ARQT $31.69
- WNC $18.05
- P/E Ratio
- ARQT N/A
- WNC N/A
- Revenue Growth
- ARQT 99.50
- WNC N/A
- 52 Week Low
- ARQT $8.03
- WNC $6.78
- 52 Week High
- ARQT $18.15
- WNC $20.63
- Technical
- Relative Strength Index (RSI)
- ARQT 59.14
- WNC 49.29
- Support Level
- ARQT $16.62
- WNC $11.08
- Resistance Level
- ARQT $18.15
- WNC $11.63
- Average True Range (ATR)
- ARQT 0.69
- WNC 0.37
- MACD
- ARQT 0.01
- WNC -0.04
- Stochastic Oscillator
- ARQT 66.89
- WNC 14.00
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.
About WNC Wabash National Corporation
Wabash National Corp operates as the innovation leader of connected solutions for the transportation, logistics, and distribution industries. The Company manages its business in two operating and reportable segments: Transportation Solutions and Parts & Services. It designs and manufactures products including dry freight and refrigerated trailers, platform trailers, tank trailers, dry and refrigerated truck bodies, structural composite panels and products, trailer aerodynamic solutions, and specialty food-grade processing equipment.